Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RMPT in Relapsed/Refractory Multiple Myeloma
NCT00961467Phase 2Completed
- Sponsor
- Fondazione EMN Italy
- Start
- Feb 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in multiple myeloma (MM), sponsored by Fondazione EMN Italy. Started Feb 2007; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00961467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00961467.